High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease

Medicine (United States)

Volumn 93, Issue 7, 2014, Pages

  Huang, Wen Hung ^a,b   Chen, Chao Yu ^a,b   Lin, Ja Liang ^a,b   Lin Tan, Dan Tzu ^a,b   Hsu, Ching Wei ^a,b   Yen, Tzung Hai ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BODY MASS INDEX; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84905722280     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000041     Document Type: Article

References (45)

1. Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with noninsulindependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med. 1996;335:1636-1642. (Pubitemid 26392728)
2. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000;278:F817-F822. (Pubitemid 30351084)
3. Porter LE, Hollenberg NK. Obesity, salt intake, and renal perfusion in healthy humans. Hypertension. 1998;32:144-148. (Pubitemid 28324138)
4. Reisin E, Messerli FG, Ventura HO, et al. Renal haemodynamic studies in obesity hypertension. J Hypertens. 1987;5:397-400. (Pubitemid 17126231)
5. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995;26:610-615.
6. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int. 2001; 59:1498-1509. (Pubitemid 32281241)
7. Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest. 1980;40:695-702. (Pubitemid 11144112)
8. Degoulet P, Legrain M, Reach I, et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron. 1982;31:103-110. (Pubitemid 12045139)
9. Kopple JD, Zhu X, Lew NL, et al. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56:1136-1148. (Pubitemid 29411743)
10. Port FK, Ashby VB, Dhingra RK, et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13:1061-1066. (Pubitemid 34274104)
11. Johansen KL, Young B, Kaysen GA, et al. Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr. 2004;80:324-332. (Pubitemid 41080005)
12. Lin JL, Lin-Tan DT, Yu CC, et al. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes. Kidney Int. 2006;69:2049-2056.
13. Isaksson B. Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr. 1980;33:4-5.
14. Leung TK, Luk AO, So WY, et al. Development and validation of equations estimating glomerular filtration rates in Chinese patients with type 2 diabetes. Kidney Int. 2010;77:729-735.
15. Anuurad E, Shiwaku K, Nogi A, et al. The new criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health. 2003;45:335-343. (Pubitemid 38036188)
16. Wen CP, David Cheng TY, Tsai SP, et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009;12:497-506.
17. Lin JL, Lin-Tan DT, Hsu KH, et al. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003;348:277-286.
18. Tsaih SW, Korrick S, Schwartz J, et al. Lead, diabetes, hypertension, and renal function: The normative aging study. Environ Health Perspect. 2004;112:1178-1182. (Pubitemid 39157619)
19. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 16 1999;130:461-470. (Pubitemid 29135798)
20. Lemley KV, Boothroyd DB, Blouch KL, et al. Modeling GFR trajectories in diabetic nephropathy. Am J Physiol Renal Physiol. 2005;289:F863-F870. (Pubitemid 41324207)
21. Myers BD, Boothroyd D, Olshen RA. Angiotensin-converting enzyme inhibitor for slowing progression of diabetic and nondiabetic kidney disease. J Am Soc Nephrol. 1998;9:S66-S70.
22. Hall JE, Crook ED, Jones DW, et al. Mechanisms of obesityassociated cardiovascular and renal disease. Am J Med Sci. 2002;324:127-137.
23. Ikizler TA. Resolved: Being fat is good for dialysis patients: The Godzilla effect: Pro. J Am Soc Nephrol. 2008;19:1059-1062.
24. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83:461S-465S. (Pubitemid 44713219)
25. Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971-E975. (Pubitemid 30045988)
26. Demas GE, Drazen DL, Nelson RJ. Reductions in total body fat decrease humoral immunity. Proc Biol Sci. 2003;270:905-911. (Pubitemid 36561025)
27. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial. 2004;17:229-232. (Pubitemid 38824505)
28. Festa A, D'Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102:42-47. (Pubitemid 30430551)
29. Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17:953-966. (Pubitemid 34020662)
30. Margetic S, Gazzola C, Pegg GG, et al. Leptin: A review of its peripheral actions and interactions. Int J Obes Relat Metab Disord. 2002;26:1407-1433. (Pubitemid 36007818)
31. Lembo G, Vecchione C, Fratta L, et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes. 2000;49:293-297. (Pubitemid 30071008)
32. Fouque D, Wang P, Laville M, et al. Low protein diets delay endstage renal disease in nondiabetic adults with chronic renal failure. Nephrol Dial Transplant. 2000;15:1986-1992.
33. Levey AS, Greene T, Sarnak MJ, et al. Effect of dietary protein restriction on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis. 2006;48:879-888. (Pubitemid 44895372)
34. Chauveau P, Aparicio M. Benefits in nutritional interventions in patients with CKD stage 3-4. J Ren Nutr. 2011;21:20-22.
35. Fouque D, Aparicio M. Eleven reasons to control the protein intake of patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:383-392. (Pubitemid 46987805)
36. Fouque D, Laville M. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev. 2009;3: CD001892.
37. Brunori G, Viola BF, Parrinello G, et al. Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: A prospective randomized multicenter controlled study. Am J Kidney Dis. 2007;49:569-580. (Pubitemid 46667194)
38. Chang JH, Kim DK, Park JT, et al. Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low-protein diet. Nephrology. 2009;14:750-757.
39. Yen TH, Lin JL, Lin-Tan DT, et al. Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial. 2010;14:400-408.
40. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr. 2005;15:142-147. (Pubitemid 40093699)
41. Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutritioninflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis. 2003;42:864-881. (Pubitemid 37322905)
42. Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis. 1998;32:834-841. (Pubitemid 28516318)
43. Ritz E. Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab. 1996;22:9-12. (Pubitemid 126448795)
44. Kalantar-Zadeh K, Kopple JD. Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38:1343-1350. (Pubitemid 34193125)
45. Kaizu Y, Tsunega Y, Yoneyama T, et al. Overweight as another nutritional risk factor for the long-term survival of nondiabetic hemodialysis patients. Clin Nephrol. 1998;50:44-50. (Pubitemid 28349773)